Chinese Patients With BCR::ABL1-Negative Myeloproliferative Neoplasms: Immunophenotype of Myeloid Monocytes

被引:0
|
作者
Liang, Fengting [1 ]
Zou, Yangyang [1 ]
Huang, Liangmei [1 ]
Pang, Dongxiao [1 ]
JinbaoPang, Xuelan
Liang, Xuelan [2 ]
机构
[1] Bobai Cty Peoples Hosp, Yulin, Peoples R China
[2] Shanxi Med Univ, Hosp 2, Taiyuan, Peoples R China
关键词
immunophenotypic analysis; monocytes; myeloproliferative syndromes;
D O I
10.1111/ijlh.14461
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe main terms for typical BCR::ABL1-negative myeloproliferative neoplasms (MPNs) are essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). Monocytes in MPN patients are involved in their inflammation and form an important part of the pathophysiology of MPN patients.MethodsWe used flow cytometry to study the immunophenotype of bone marrow monocytes from MPN patients (N = 118) and to correlate it with clinical parameters (including genetics, pathology, blood counts, personal information).ResultsThe results showed that bone marrow monocyte cells from MPN patients expressed the inflammation-related marker CD16 at higher levels than healthy controls. Second, bone marrow monocytes from Overt-PMF patients expressed CD11b at higher levels than monocytes from ET patients. Finally, certain specific monocyte subpopulations in MPN patients correlated with their clinical parameters. For example, in patients with ET and PMF, CD64+ monocytes were positively correlated with WBC and LDH. In PMF patients, the proportion of bone marrow monocytes was positively correlated with the grade of myelofibrosis, and CD15+ monocytes positively correlated with WBC and IPSS scores.ConclusionOur results provide insights into the immune microenvironment of MPNs based on immunophenotypic features and provide potential immune markers for MPNs occurrence and development.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Increased mRNA expression for serotonin receptor 1B (HTR1B) is associated with thrombosis in BCR::ABL1-negative myeloproliferative neoplasms
    Gurban, Petruta
    Mambet, Cristina
    Botezatu, Anca
    Necula, Laura G.
    Matei, Lilia
    Neagu, Ana Iulia
    Pitica, Ioana Madalina
    Dragu, Laura Denisa
    Schulman, Alina Nastasie
    Ataman, Marius
    Nedeianu, Saviana
    Chivu-Economescu, Mihaela
    Bleotu, Coralia
    Anton, Gabriela
    Diaconu, Carmen Cristina
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (16)
  • [32] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1054 - 1054
  • [33] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1054 - 1054
  • [34] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    LABORATORY INVESTIGATION, 2016, 96 : 340A - 340A
  • [35] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
    Yuen, Lisa
    Gogakos, Tasos
    Boiocchi, Leonardo
    Hobbs, Gabriela
    Hasserjian, Robert
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1048 - 1049
  • [36] The Role of Mutated Calreticulin in the Pathogenesis of BCR-ABL1-Negative Myeloproliferative Neoplasms
    Vadeikiene, Roberta
    Jakstys, Baltramiejus
    Laukaitiene, Danguole
    Satkauskas, Saulius
    Juozaityte, Elona
    Ugenskiene, Rasa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (18)
  • [37] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
    Yuen, Lisa
    Gogakos, Tasos
    Boiocchi, Leonardo
    Hobbs, Gabriela
    Hasserjian, Robert
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1048 - 1049
  • [38] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    MODERN PATHOLOGY, 2016, 29 : 340A - 340A
  • [39] GENETIC ABNORMALITIES IN DIAGNOSTICS OF BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Kozlovskaya, M.
    Martynkevich, I.
    Petrova, E.
    Martynenko, L.
    Ivanova, M.
    Cybakova, N.
    Gritsaev, S.
    Shuvaev, V.
    Abdulkadyrov, K.
    HAEMATOLOGICA, 2013, 98 : 618 - 618
  • [40] Prevention and Management of Thrombosis in BCR/ABL-Negative Myeloproliferative Neoplasms
    Falanga, Anna
    Marchetti, Marina
    Schieppati, Francesca
    HAMOSTASEOLOGIE, 2021, 41 (01): : 48 - 57